QURE
uniQure N.V.
Company overview
- Market capitalization
- $2.47B
- Employees
- 221
- Latest publication
- 2026-09-29
About uniQure N.V.
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q4 20222022-12-31 · USD | Q3 20222022-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,841,000USD | 3,562,000USD | 3,701,000USD | 5,262,000USD | 1,567,000USD | 5,221,000USD | 102,745,000USD | 1,449,000USD |
| Cost Of Revenue | 350,000USD | 219,000USD | 398,000USD | 656,000USD | 197,000USD | 619,000USD | 1,650,000USD | 861,000USD |
| Gross Profit | 5,491,000USD | 3,343,000USD | 3,303,000USD | 4,606,000USD | 1,370,000USD | 4,602,000USD | 101,095,000USD | 588,000USD |
| Research Development | 33,964,000USD | 29,176,000USD | 34,366,000USD | 35,383,000USD | 36,140,000USD | 38,840,000USD | 58,328,000USD | 48,068,000USD |
| Selling General Administrative | 17,367,000USD | 20,068,000USD | 19,438,000USD | 13,500,000USD | 10,908,000USD | 9,403,000USD | 18,257,000USD | 13,523,000USD |
| Total Operating Expenses | 57,694,000USD | 47,612,000USD | 54,338,000USD | 48,471,000USD | 40,701,000USD | 50,430,000USD | 74,594,000USD | 60,106,000USD |
| Operating Income | -52,203,000USD | -44,269,000USD | -51,035,000USD | -43,865,000USD | -39,331,000USD | -45,828,000USD | 26,501,000USD | -59,518,000USD |
| Total Other Income Expense Net | -27,015,000USD | -8,778,000USD | -20,868,000USD | 6,571,000USD | -3,810,000USD | -26,577,000USD | -19,901,000USD | 11,332,000USD |
| Interest Income | 5,051,000USD | 5,229,000USD | 3,503,000USD | 3,524,000USD | 4,127,000USD | 4,236,000USD | 492,000USD | 39,000USD |
| Interest Expense | 14,366,000USD | 14,031,000USD | 16,721,000USD | 15,591,000USD | 15,109,000USD | 14,876,000USD | 3,425,000USD | 3,069,000USD |
| Income Before Tax | -79,218,000USD | -53,047,000USD | -71,903,000USD | -37,294,000USD | -43,141,000USD | -72,405,000USD | 6,600,000USD | -48,186,000USD |
| Income Tax Expense | 1,841,000USD | 488,000USD | 8,626,000USD | 425,000USD | 496,000USD | 856,000USD | -207,000USD | -329,000USD |
| Net Income | -81,059,000USD | -53,535,000USD | -80,529,000USD | -37,719,000USD | -43,637,000USD | -73,261,000USD | 6,807,000USD | -47,857,000USD |
| Unclassified Operating Expenses | — | -1,632,000USD | — | — | -6,347,000USD | 2,187,000USD | -1,991,000USD | -1,485,000USD |
| Net Interest Income | — | -8,802,000USD | -14,718,000USD | -12,067,000USD | -10,982,000USD | -10,640,000USD | -2,933,000USD | -3,030,000USD |
| Tax Provision | — | 488,000USD | 8,626,000USD | 425,000USD | 496,000USD | 856,000USD | -207,000USD | -329,000USD |
| Net Income From Continuing Ops | — | -53,535,000USD | -80,529,000USD | -37,719,000USD | -43,637,000USD | -73,261,000USD | 6,807,000USD | -47,857,000USD |
| Ebit | — | -39,016,000USD | -55,182,000USD | -21,703,000USD | -28,032,000USD | -57,529,000USD | 25,772,000USD | -45,117,000USD |
| Ebitda | — | -36,060,000USD | -51,550,000USD | -18,073,000USD | -23,505,000USD | -53,173,000USD | 28,103,000USD | -43,014,000USD |
| Depreciation And Amortization | — | 2,956,000USD | 3,632,000USD | 3,630,000USD | 4,527,000USD | 4,356,000USD | 2,331,000USD | 2,103,000USD |
| Reconciled Depreciation | — | 2,956,000USD | 3,632,000USD | 3,630,000USD | 4,527,000USD | 4,356,000USD | 2,331,000USD | 2,103,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | 6,807,000USD | -47,857,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 14,401,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16,098,000USD | 524,002,000USD | 11,284,000USD | 13,107,000USD | 25,098,000USD | 10,304,375USD | — | — |
| Cost Of Revenue | 1,686,000USD | 24,976,000USD | 73,060,000USD | 67,409,000USD | 72,690,000USD | 638,488USD | 13,489,353USD | — |
| Gross Profit | 14,412,000USD | 499,026,000USD | -61,776,000USD | -54,302,000USD | 25,098,000USD | 9,665,887USD | -13,489,353USD | — |
| Research Development | 140,673,000USD | 143,548,000USD | 74,809,000USD | 72,383,000USD | 72,510,000USD | 51,145,780USD | 13,530,563USD | 20,089,430USD |
| Selling General Administrative | 65,337,000USD | 57,166,000USD | 25,305,000USD | 24,635,000USD | 24,534,000USD | 23,383,000USD | 6,035,919USD | — |
| Unclassified Operating Expenses | -3,771,000USD | -12,306,000USD | — | -11,954,000USD | — | -2,766,596USD | — | 2,126,887USD |
| Total Operating Expenses | 202,239,000USD | 188,408,000USD | 99,516,000USD | 85,064,000USD | 97,044,000USD | 71,762,184USD | 18,767,688USD | 22,216,317USD |
| Operating Income | -187,827,000USD | 310,618,000USD | -88,232,000USD | -71,957,000USD | -71,946,000USD | -74,822,338USD | -18,767,689USD | -22,216,318USD |
| Interest Income | 16,967,000USD | 162,000USD | 2,729,000USD | 117,000USD | 70,000USD | 4,947,000USD | — | — |
| Interest Expense | 61,994,000USD | 7,474,000USD | 2,160,000USD | 2,475,000USD | 2,172,000USD | 2,572,000USD | 109,768USD | 509,364USD |
| Net Interest Income | -45,027,000USD | -7,312,000USD | 569,000USD | -2,358,000USD | -2,102,000USD | — | — | — |
| Income Before Tax | -193,340,000USD | 332,806,000USD | -83,073,000USD | -80,588,000USD | -72,229,000USD | -78,620,471USD | -19,462,004USD | -22,422,396USD |
| Income Tax Expense | 5,631,000USD | 3,217,000USD | 231,000USD | -199,000USD | 1,145,000USD | 471,213USD | 109,768USD | 509,364USD |
| Tax Provision | 5,631,000USD | 3,217,000USD | 231,000USD | -199,000USD | 1,145,000USD | -1,179,000USD | — | — |
| Net Income | -198,971,000USD | 329,589,000USD | -83,304,000USD | -80,389,000USD | -73,374,000USD | -78,149,258USD | -19,462,004USD | -22,422,396USD |
| Net Income From Continuing Ops | -198,971,000USD | 329,589,000USD | -83,304,000USD | -79,260,000USD | -73,374,000USD | -82,083,000USD | — | — |
| Ebit | -131,346,000USD | 311,701,000USD | -80,913,000USD | -77,280,000USD | -71,946,000USD | -77,332,181USD | -18,816,483USD | -23,397,371USD |
| Ebitda | -116,587,000USD | 319,000,000USD | -74,013,000USD | -69,737,000USD | -65,857,000USD | -72,475,732USD | -18,091,750USD | -22,632,677USD |
| Depreciation And Amortization | 14,759,000USD | 7,299,000USD | 6,900,000USD | 7,543,000USD | 6,089,000USD | 4,856,449USD | 724,733USD | 764,694USD |
| Reconciled Depreciation | 14,759,000USD | 7,299,000USD | 12,415,000USD | 7,543,000USD | — | — | — | — |
| Total Other Income Expense Net | -5,513,000USD | 22,188,000USD | 5,159,000USD | -8,116,000USD | -283,000USD | -12,111,000USD | -694,316USD | 2,791,187USD |
| Non Operating Income Net Other | — | 29,662,000USD | 7,319,000USD | — | 1,889,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | 329,589,000USD | -83,304,000USD | -79,260,000USD | -73,374,000USD | -82,083,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 985,103,000USD | 778,706,000USD | 824,908,000USD | 888,382,000USD | 584,890,000USD | 605,403,000USD | 556,536,000USD | 645,806,000USD |
| Cash And Equivalents | 413,027,000USD | — | — | — | — | — | — | — |
| Long Term Investments | 30,267,000USD | 15,280,000USD | 30,237,000USD | 30,000,000USD | 29,735,000USD | 28,273,000USD | 27,464,000USD | 28,260,000USD |
| Total Current Assets | 834,269,000USD | 615,744,000USD | 655,986,000USD | 716,193,000USD | 408,573,000USD | 435,421,000USD | 390,289,000USD | 464,138,000USD |
| Other Non Current Assets | 4,535,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 661,053,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 83,345,000USD | 59,197,000USD | 62,919,000USD | 100,632,000USD | 40,929,000USD | 36,310,000USD | 40,053,000USD | 71,273,000USD |
| Other Current Liabilities | 51,133,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 2,693,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 324,050,000USD | 149,343,000USD | 198,901,000USD | 228,746,000USD | -4,003,000USD | 33,686,000USD | -6,752,000USD | 55,821,000USD |
| Total Equity Including Noncontrolling Interest | 324,050,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 50,147,000USD | 49,942,000USD | 49,699,000USD | 51,880,000USD | 51,842,000USD | 51,592,000USD | 51,324,000USD | 51,113,000USD |
| Net Receivables | 5,778,000USD | 3,562,000USD | 5,863,000USD | 3,883,000USD | 5,606,000USD | 2,522,000USD | 5,881,000USD | 5,322,000USD |
| Property Plant Equipment Net | 22,982,000USD | 24,275,000USD | 26,325,000USD | 28,481,000USD | 31,127,000USD | 31,547,000USD | 34,071,000USD | 40,399,000USD |
| Goodwill | 24,587,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 62,101,000USD | 69,990,000USD | 72,790,000USD | 74,144,000USD | 75,604,000USD | 71,992,000USD | 71,043,000USD | 76,609,000USD |
| Accounts Payable | 4,979,000USD | 4,399,000USD | 5,170,000USD | 6,228,000USD | 5,541,000USD | 5,268,000USD | 7,227,000USD | 5,441,000USD |
| Short Term Debt | 2,991,000USD | 2,992,000USD | 3,862,000USD | 3,914,000USD | 3,909,000USD | 3,698,000USD | 3,601,000USD | 11,024,000USD |
| Common Stock | 4,086,000USD | 3,728,000USD | 3,688,000USD | 3,678,000USD | 3,250,000USD | 3,240,000USD | 2,945,000USD | 2,932,000USD |
| Retained Earnings | -1,463,530,000USD | -1,382,471,000USD | -1,328,936,000USD | -1,291,850,000USD | -1,211,321,000USD | -1,173,602,000USD | -1,129,965,000USD | -1,056,704,000USD |
| Accumulated Other Comprehensive Income | -58,251,000USD | -59,885,000USD | -58,222,000USD | -58,745,000USD | -58,903,000USD | -53,805,000USD | -52,800,000USD | -56,698,000USD |
| Other Current Assets | — | 25,632,000USD | 27,582,000USD | 18,065,000USD | 25,993,000USD | 23,888,000USD | 16,887,000USD | 23,575,000USD |
| Total Liab | — | 629,363,000USD | 626,007,000USD | 659,636,000USD | 588,893,000USD | 571,717,000USD | 563,288,000USD | 589,985,000USD |
| Other Current Liab | — | 51,806,000USD | 33,397,000USD | 82,669,000USD | 31,479,000USD | 27,344,000USD | 29,225,000USD | 42,458,000USD |
| Capital Stock | — | 3,728,000USD | 3,688,000USD | 3,678,000USD | 3,250,000USD | 3,240,000USD | 2,945,000USD | 2,932,000USD |
| Good Will | — | 24,811,000USD | 25,355,000USD | 25,327,000USD | 25,340,000USD | 23,351,000USD | 22,414,000USD | 24,084,000USD |
| Cash | — | 139,994,000USD | 80,240,000USD | 597,056,000USD | 253,778,000USD | 217,229,000USD | 158,930,000USD | 251,626,000USD |
| Cash And Short Term Investments | — | 586,550,000USD | 622,541,000USD | 694,245,000USD | 376,974,000USD | 409,011,000USD | 367,521,000USD | 435,241,000USD |
| Net Debt | — | -76,672,000USD | 456,352,000USD | -530,901,000USD | -187,081,000USD | -151,033,000USD | -92,869,000USD | 249,383,000USD |
| Short Long Term Debt Total | — | 63,322,000USD | 536,592,000USD | 66,155,000USD | 66,697,000USD | 66,196,000USD | 66,061,000USD | 501,009,000USD |
| Short Term Investments | — | 446,556,000USD | 542,301,000USD | 97,189,000USD | 123,196,000USD | 191,782,000USD | 208,591,000USD | 183,615,000USD |
| Property Plant Equipment Gross | — | 24,275,000USD | 70,061,000USD | 71,981,000USD | 72,427,000USD | 67,647,000USD | 65,727,000USD | 71,199,000USD |
| Common Stock Shares Outstanding | — | 62,742,847shares | 57,502,068shares | 58,516,415shares | 54,807,967shares | 53,111,000shares | 48,840,666shares | 48,718,533shares |
| Non Current Assets Total | — | 162,962,000USD | 168,922,000USD | 172,189,000USD | 176,317,000USD | 169,982,000USD | 166,247,000USD | 181,668,000USD |
| Non Current Liabilities Total | — | 570,166,000USD | 563,088,000USD | 559,004,000USD | 547,964,000USD | 535,407,000USD | 523,235,000USD | 518,712,000USD |
| Non Current Liabilities Other | — | 502,040,000USD | 495,590,000USD | 488,805,000USD | 477,213,000USD | 465,571,000USD | 453,732,000USD | 447,787,000USD |
| Non Currrent Assets Other | — | 5,542,000USD | 5,561,000USD | 5,465,000USD | 5,494,000USD | 5,429,000USD | 1,399,000USD | 1,453,000USD |
| Net Working Capital | — | 556,547,000USD | 593,067,000USD | 615,561,000USD | 367,644,000USD | 399,111,000USD | 350,236,000USD | 392,865,000USD |
| Unclassified Non Current Assets | — | 23,064,000USD | 8,654,000USD | 8,772,000USD | 9,017,000USD | 9,390,000USD | 9,856,000USD | 10,863,000USD |
| Unclassified Non Current Liabilities | — | 18,184,000USD | 17,799,000USD | 18,319,000USD | 18,909,000USD | 18,244,000USD | 18,179,000USD | 19,812,000USD |
| Unclassified Equity | — | 1,584,243,000USD | 1,578,683,000USD | 1,571,985,000USD | 1,259,721,000USD | 1,254,613,000USD | 1,170,123,000USD | 1,163,359,000USD |
| Current Deferred Revenue | — | — | 20,490,000USD | — | 13,878,000USD | — | — | 12,350,000USD |
| Unclassified Current Liabilities | — | — | — | 7,821,000USD | -13,878,000USD | — | — | — |
| Inventory | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 824,908,000USD | 556,536,000USD | 831,689,000USD | 704,964,000USD | 809,180,000USD | 340,395,000USD | 448,630,000USD | 273,906,000USD |
| Intangible Assets | 72,790,000USD | 71,043,000USD | 60,481,000USD | 58,778,000USD | 62,686,000USD | 3,361,000USD | 5,427,000USD | 5,201,000USD |
| Other Current Assets | 27,582,000USD | 16,887,000USD | 17,744,000USD | 14,631,000USD | 13,215,000USD | 7,361,000USD | 748,000USD | 329,000USD |
| Total Liab | 626,007,000USD | 563,288,000USD | 624,019,000USD | 228,955,000USD | 213,404,000USD | 96,490,000USD | 125,572,000USD | 94,300,000USD |
| Total Stockholder Equity | 198,901,000USD | -6,752,000USD | 207,670,000USD | 476,009,000USD | 595,776,000USD | 243,905,000USD | 323,058,000USD | 179,606,000USD |
| Other Current Liab | 33,397,000USD | 29,225,000USD | 58,745,000USD | 45,433,000USD | 15,475,000USD | 15,956,000USD | 12,457,000USD | 545,000USD |
| Common Stock | 3,688,000USD | 2,945,000USD | 2,883,000USD | 2,838,000USD | 2,802,000USD | 2,711,000USD | 2,651,000USD | 2,299,000USD |
| Capital Stock | 3,688,000USD | 2,945,000USD | 2,883,000USD | 2,838,000USD | 2,802,000USD | 2,711,000USD | 2,651,000USD | 2,299,000USD |
| Retained Earnings | -1,328,936,000USD | -1,129,965,000USD | -890,409,000USD | -581,931,000USD | -455,142,000USD | -784,731,000USD | -659,707,000USD | -535,506,000USD |
| Good Will | 25,355,000USD | 22,414,000USD | 26,379,000USD | 25,581,000USD | 27,633,000USD | 542,000USD | 496,000USD | 506,000USD |
| Cash | 80,240,000USD | 158,930,000USD | 241,360,000USD | 228,012,000USD | 556,256,000USD | 244,932,000USD | 377,793,000USD | 234,898,000USD |
| Cash And Short Term Investments | 622,541,000USD | 367,521,000USD | 617,892,000USD | 352,843,000USD | 556,256,000USD | 244,932,000USD | 377,793,000USD | 234,898,000USD |
| Total Current Assets | 655,986,000USD | 390,289,000USD | 651,853,000USD | 476,774,000USD | 628,239,000USD | 258,911,000USD | 384,206,000USD | 236,576,000USD |
| Total Current Liabilities | 62,919,000USD | 40,053,000USD | 73,675,000USD | 75,919,000USD | 36,763,000USD | 27,334,000USD | 31,630,000USD | 19,969,000USD |
| Current Deferred Revenue | 20,490,000USD | — | 29,097,000USD | 11,120,000USD | 13,012,000USD | 2,082,000USD | 7,627,000USD | 7,634,000USD |
| Net Debt | 456,352,000USD | -92,869,000USD | -102,951,000USD | -85,120,000USD | -420,532,000USD | -173,388,000USD | -304,733,000USD | -199,427,000USD |
| Short Term Debt | 3,862,000USD | 3,601,000USD | 8,344,000USD | 8,382,000USD | 5,774,000USD | 5,524,000USD | 5,865,000USD | 7,998,000USD |
| Short Long Term Debt Total | 536,592,000USD | 66,061,000USD | 138,409,000USD | 142,892,000USD | 135,724,000USD | 71,544,000USD | 73,060,000USD | 43,469,000USD |
| Long Term Debt | 49,699,000USD | 51,324,000USD | 101,749,000USD | 102,791,000USD | 100,963,000USD | 35,617,000USD | 36,062,000USD | 35,471,000USD |
| Long Term Investments | 30,237,000USD | 27,464,000USD | 2,179,000USD | 39,984,000USD | 0USD | — | — | — |
| Short Term Investments | 542,301,000USD | 208,591,000USD | 376,532,000USD | 124,831,000USD | 0USD | — | — | — |
| Net Receivables | 5,863,000USD | 5,881,000USD | 4,193,000USD | 102,376,000USD | 58,768,000USD | 6,618,000USD | 947,000USD | 233,000USD |
| Accounts Payable | 5,170,000USD | 7,227,000USD | 6,586,000USD | 10,984,000USD | 2,502,000USD | 3,772,000USD | 5,681,000USD | 3,792,000USD |
| Property Plant Equipment Net | 26,325,000USD | 34,071,000USD | 75,337,000USD | 83,258,000USD | 69,078,000USD | 58,414,000USD | 55,568,000USD | 29,179,000USD |
| Property Plant Equipment Gross | 70,061,000USD | 65,727,000USD | 131,009,000USD | 127,384,000USD | 43,505,000USD | 58,414,000USD | 28,771,000USD | 29,179,000USD |
| Accumulated Other Comprehensive Income | -58,222,000USD | -52,800,000USD | -53,553,000USD | -58,291,000USD | -28,856,000USD | 9,907,000USD | -6,689,000USD | -7,259,000USD |
| Common Stock Shares Outstanding | 57,502,068shares | 48,649,000shares | 47,670,986shares | 46,735,045shares | 46,840,972shares | 44,466,365shares | 39,999,450shares | 35,639,745shares |
| Non Current Assets Total | 168,922,000USD | 166,247,000USD | 179,836,000USD | 228,190,000USD | 180,941,000USD | 81,484,000USD | 64,424,000USD | 37,330,000USD |
| Non Current Liabilities Total | 563,088,000USD | 523,235,000USD | 550,344,000USD | 153,036,000USD | 176,641,000USD | 69,156,000USD | 93,942,000USD | 74,331,000USD |
| Non Current Liabilities Other | 495,590,000USD | 453,732,000USD | 412,736,000USD | 10,269,000USD | 176,641,000USD | 69,156,000USD | 93,942,000USD | 74,331,000USD |
| Non Currrent Assets Other | 5,561,000USD | 1,399,000USD | 3,184,000USD | 6,061,000USD | 5,897,000USD | 2,748,000USD | 2,933,000USD | 2,444,000USD |
| Net Working Capital | 593,067,000USD | 350,236,000USD | 578,178,000USD | 400,855,000USD | 591,476,000USD | 231,577,000USD | 352,576,000USD | 216,607,000USD |
| Unclassified Non Current Assets | 8,654,000USD | 9,856,000USD | 12,276,000USD | -6,061,000USD | -5,897,000USD | -28,834,000USD | -2,933,000USD | -2,444,000USD |
| Unclassified Non Current Liabilities | 17,799,000USD | 18,179,000USD | 35,859,000USD | 21,450,000USD | -147,654,000USD | -38,753,000USD | -62,809,000USD | -74,331,000USD |
| Unclassified Equity | 1,578,683,000USD | 1,170,123,000USD | 1,145,866,000USD | 1,110,555,000USD | 1,074,170,000USD | 1,013,307,000USD | 984,152,000USD | 717,773,000USD |
| Inventory | — | 0USD | 12,024,000USD | 6,924,000USD | 10,540,000USD | 4,337,000USD | 4,718,000USD | 1,116,000USD |
| Unclassified Current Liabilities | — | — | -29,097,000USD | — | — | — | — | — |
| Other Liab | — | — | — | 18,526,000USD | 46,691,000USD | 3,136,000USD | 26,747,000USD | 38,860,000USD |
| Other Assets | — | — | — | 20,589,000USD | 21,544,000USD | 45,253,000USD | 2,933,000USD | 2,444,000USD |
| Net Tangible Assets | — | — | — | 391,650,000USD | 595,776,000USD | 243,905,000USD | 323,058,000USD | 179,606,000USD |
| Unclassified Current Assets | — | — | — | — | -10,540,000USD | -4,337,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -53,535,000USD | -37,086,000USD | -80,529,000USD | -37,719,000USD | -43,637,000USD | -73,261,000USD | -44,378,000USD | -56,299,000USD |
| Depreciation | 2,956,000USD | 2,970,000USD | 3,632,000USD | -3,630,000USD | 4,527,000USD | 4,356,000USD | 2,986,000USD | 2,670,000USD |
| Stock Based Compensation | 5,090,000USD | 4,663,000USD | 3,522,000USD | 5,084,000USD | 4,410,000USD | 4,749,000USD | 3,438,000USD | 6,880,000USD |
| Other Non Cash Items | -333,000USD | -12,814,000USD | 15,467,000USD | 1,998,000USD | -3,619,000USD | -1,834,000USD | -3,625,000USD | 12,777,000USD |
| Change To Account Receivables | 3,780,000USD | -11,477,000USD | 9,641,000USD | -3,782,000USD | -2,979,000USD | 3,521,000USD | 1,463,000USD | 3,190,000USD |
| Change In Working Capital | 7,121,000USD | -34,911,000USD | 40,451,000USD | -6,053,000USD | -6,277,000USD | 12,290,000USD | 5,012,000USD | 313,000USD |
| Total Cash From Operating Activities | -38,243,000USD | -77,569,000USD | -16,399,000USD | -39,895,000USD | -44,100,000USD | -52,844,000USD | -36,598,000USD | -32,711,000USD |
| Capital Expenditures | -140,000USD | -320,000USD | -66,000USD | -260,000USD | -126,000USD | -61,000USD | -8,680,000USD | -604,000USD |
| Free Cash Flow | -38,383,000USD | -77,249,000USD | -16,333,000USD | -40,155,000USD | -44,226,000USD | -52,905,000USD | -45,278,000USD | -33,315,000USD |
| Investments | 98,700,000USD | -441,251,000USD | 26,579,000USD | 73,073,000USD | 20,099,000USD | -26,624,000USD | 47,670,000USD | 77,937,000USD |
| Total Cashflows From Investing Activities | 98,560,000USD | -456,963,131USD | 26,579,000USD | 73,073,000USD | 20,099,000USD | -26,624,000USD | 47,670,000USD | 77,937,000USD |
| Total Cash From Financing Activities | 550,000USD | -3,566,327USD | 332,235,000USD | 44,000USD | 80,670,000USD | -6,517,000USD | -53,019,000USD | 50,000USD |
| Issuance Of Capital Stock | 550,000USD | 2,449,000USD | 308,736,000USD | 44,000USD | 80,670,000USD | 2,042,000USD | 31,000USD | 50,000USD |
| Change In Cash | 59,735,000USD | -516,816,000USD | 343,277,000USD | 36,614,000USD | 58,329,000USD | -92,750,000USD | -37,960,000USD | 44,810,000USD |
| Begin Period Cash Flow | 81,801,000USD | 598,549,000USD | 255,272,000USD | 218,658,000USD | 160,329,000USD | 253,079,000USD | 291,039,000USD | 246,229,000USD |
| End Period Cash Flow | 141,536,000USD | 81,802,000USD | 598,549,000USD | 255,272,000USD | 218,658,000USD | 160,329,000USD | 253,079,000USD | 291,039,000USD |
| Other Cashflows From Investing Activities | 98,700,000USD | -357,437,131USD | — | — | 20,225,000USD | -283,571USD | 200,774,242USD | 78,541,000USD |
| Other Cashflows From Financing Activities | 550,000USD | 388,998,014USD | 23,499,000USD | -3,114,341USD | 80,511,000USD | -8,559,000USD | -53,050,000USD | -200USD |
| Unclassified Investing Cash Flow | -98,700,000USD | 342,045,000USD | — | — | -20,099,000USD | — | -192,094,242USD | -77,937,000USD |
| Change To Inventory | — | 0USD | 0USD | 0USD | 0USD | 6,297,000USD | -1,270,000USD | -4,842,000USD |
| Net Borrowings | — | 0USD | — | — | — | 0USD | — | — |
| Unclassified Financing Cash Flow | — | -395,013,341USD | — | 3,114,341USD | -80,511,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | 1,058,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -198,971,000USD | -239,556,000USD | -308,478,000USD | -126,789,000USD | 329,589,000USD | -125,024,000USD | -124,201,000USD | -83,304,000USD |
| Depreciation | 14,759,000USD | 12,641,000USD | 11,900,000USD | 8,537,000USD | 7,299,000USD | 10,648,000USD | 6,669,000USD | 12,415,000USD |
| Stock Based Compensation | 17,679,000USD | 22,258,000USD | 35,093,000USD | 34,204,000USD | 25,635,000USD | 21,831,000USD | 17,533,000USD | 10,708,000USD |
| Other Non Cash Items | -6,228,000USD | 23,444,000USD | 32,512,000USD | -16,158,000USD | -27,292,000USD | -19,395,000USD | 3,421,000USD | -9,886,000USD |
| Change To Account Receivables | -8,597,000USD | -2,243,000USD | -1,323,000USD | -49,083,000USD | -58,959,000USD | -6,967,000USD | -4,769,000USD | 1,578,000USD |
| Change To Inventory | 0USD | 2,421,000USD | -6,740,000USD | -6,924,000USD | -6,924,000USD | 6,967,000USD | 4,769,000USD | -382,000USD |
| Change In Working Capital | -6,789,999USD | -3,944,000USD | 81,123,000USD | -43,384,000USD | -50,482,000USD | -6,469,000USD | -2,106,000USD | -6,201,000USD |
| Total Cash From Operating Activities | -177,963,000USD | -182,728,000USD | -145,929,000USD | -145,060,000USD | 287,959,000USD | -134,828,000USD | -98,684,000USD | -76,037,000USD |
| Capital Expenditures | -439,000USD | -3,368,000USD | -7,154,000USD | -17,688,000USD | -17,438,000USD | -9,484,000USD | -6,647,000USD | -4,245,000USD |
| Free Cash Flow | -177,963,000USD | -186,096,000USD | -153,083,000USD | -162,748,000USD | 270,521,000USD | -144,312,000USD | -105,331,000USD | -80,282,000USD |
| Investments | -321,180,000USD | 162,968,000USD | -433,460,000USD | -182,734,000USD | -67,387,000USD | -9,484,000USD | -6,647,000USD | -4,245,000USD |
| Total Cashflows From Investing Activities | -321,619,000USD | 162,968,000USD | -205,686,000USD | -182,734,000USD | -67,387,000USD | -9,484,000USD | -6,647,000USD | -4,245,000USD |
| Net Borrowings | 0USD | -53,050,000USD | 0USD | 0USD | 62,495,000USD | 62,495,000USD | 62,495,000USD | 14,775,000USD |
| Total Cash From Financing Activities | 415,398,000USD | -59,486,000USD | 362,721,000USD | 1,445,000USD | 94,858,000USD | 7,444,000USD | 248,821,000USD | 157,961,000USD |
| Issuance Of Capital Stock | 391,899,000USD | 2,123,000USD | 863,000USD | 1,445,000USD | 30,899,000USD | -295,000USD | 242,718,000USD | 138,361,000USD |
| Change In Cash | -78,690,000USD | -84,215,000USD | 13,371,000USD | -328,180,000USD | 311,673,000USD | -133,046,000USD | 143,384,000USD | 75,491,000USD |
| Begin Period Cash Flow | 158,930,000USD | 244,544,000USD | 231,173,000USD | 559,353,000USD | 247,680,000USD | 380,726,000USD | 237,342,000USD | 161,851,000USD |
| End Period Cash Flow | 80,240,000USD | 160,329,000USD | 244,544,000USD | 231,173,000USD | 559,353,000USD | 247,680,000USD | 380,726,000USD | 237,342,000USD |
| Other Cashflows From Financing Activities | 23,499,000USD | -8,559,000USD | -7,649,000USD | -182,734,000USD | -1,334,000USD | -9,484,000USD | 6,103,000USD | 4,825,000USD |
| Other Cashflows From Investing Activities | — | 174,657,000USD | — | -163,146,000USD | -49,949,000USD | -2,213,000USD | -996,000USD | -1,861,000USD |
| Unclassified Operating Cash Flow | — | 2,429,000USD | 1,921,000USD | -1,470,000USD | 3,210,000USD | -16,419,000USD | — | — |
| Unclassified Investing Cash Flow | — | -171,289,000USD | 234,928,000USD | 180,834,000USD | 67,387,000USD | 11,697,000USD | 7,643,000USD | 6,106,000USD |
| Unclassified Financing Cash Flow | — | — | 369,507,000USD | 182,734,000USD | 1,334,000USD | -53,011,000USD | -68,598,000USD | -4,825,000USD |
| Change To Liabilities | — | — | — | 9,238,000USD | 8,477,000USD | 498,000USD | 7,662,000USD | 683,000USD |
| Sale Purchase Of Stock | — | — | — | — | 32,363,000USD | 7,444,000USD | 248,821,000USD | 143,186,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 315,430,000USD | -136,868,000USD | 143,490,000USD | 77,679,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Collaborative Revenue | 164,000 | USD | 0001104659-26-021898 |
| FY 2025Yearly · 2025-12-31 | Product | Contract Manufacturing Revenue | 0 | USD | 0001104659-26-021898 |
| FY 2025Yearly · 2025-12-31 | Product | License | 15,934,000 | USD | 0001104659-26-021898 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaborative Revenue | 119,000 | USD | 0001104659-25-108813 |
| Q3 2025Quarterly · 2025-09-30 | Product | License | 3,582,000 | USD | 0001104659-25-108813 |
| FY 2024Yearly · 2024-12-31 | Product | Collaborative Revenue | 10,872,000 | USD | 0001104659-26-021898 |
| FY 2024Yearly · 2024-12-31 | Product | Contract Manufacturing Revenue | 6,100,000 | USD | 0001104659-26-021898 |
| FY 2024Yearly · 2024-12-31 | Product | License | 10,133,000 | USD | 0001104659-26-021898 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaborative Revenue | 270,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Contract Manufacturing Revenue | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | License | 4,962,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaborative Revenue | 176,000 | USD | 0001558370-24-014346 |
| Q3 2024Quarterly · 2024-09-30 | Product | Contract Manufacturing Revenue | 0 | USD | 0001558370-24-014346 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 2,100,000 | USD | 0001558370-24-014346 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other | 11,000 | USD | 0001558370-24-014346 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaborative Revenue | 7,133,000 | USD | 0001558370-25-009694 |
| Q2 2024Quarterly · 2024-06-30 | Product | Contract Manufacturing Revenue | 2,124,000 | USD | 0001558370-25-009694 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 1,869,000 | USD | 0001558370-25-009694 |
| Q1 2024Quarterly · 2024-03-31 | Product | Collaborative Revenue | 3,293,000 | USD | 0001558370-25-007068 |
| Q1 2024Quarterly · 2024-03-31 | Product | Contract Manufacturing Revenue | 3,990,000 | USD | 0001558370-25-007068 |
| Q1 2024Quarterly · 2024-03-31 | Product | License | 1,202,000 | USD | 0001558370-25-007068 |
| FY 2023Yearly · 2023-12-31 | Product | Collaborative Revenue | 2,250,000 | USD | 0001104659-26-021898 |
| FY 2023Yearly · 2023-12-31 | Product | Contract Manufacturing Revenue | 10,800,000 | USD | 0001104659-26-021898 |
| FY 2023Yearly · 2023-12-31 | Product | License | 2,758,000 | USD | 0001104659-26-021898 |
| FY 2023Yearly · 2023-12-31 | Product | Other | 35,000 | USD | 0001104659-26-021898 |
| Q4 2023Quarterly · 2023-12-31 | Product | Collaborative Revenue | 982,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Contract Manufacturing Revenue | 4,204,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | License | 1,458,000 | USD | Legacy provider |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaborative Revenue | 561,000 | USD | 0001558370-24-014346 |
| Q3 2023Quarterly · 2023-09-30 | Product | Contract Manufacturing Revenue | 300,000 | USD | 0001558370-24-014346 |
| Q3 2023Quarterly · 2023-09-30 | Product | License | 500,000 | USD | 0001558370-24-014346 |
| Q3 2023Quarterly · 2023-09-30 | Product | Other | 46,000 | USD | 0001558370-24-014346 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaborative Revenue | 319,000 | USD | 0001558370-24-010528 |
| Q2 2023Quarterly · 2023-06-30 | Product | Contract Manufacturing Revenue | 1,310,000 | USD | 0001558370-24-010528 |
| Q2 2023Quarterly · 2023-06-30 | Product | License | 800,000 | USD | 0001558370-24-010528 |
| FY 2022Yearly · 2022-12-31 | Product | Collaborative Revenue | 4,766,000 | USD | 0001558370-25-001699 |
| FY 2022Yearly · 2022-12-31 | Product | Contract Manufacturing Revenue | 1,700,000 | USD | 0001558370-25-001699 |
| FY 2022Yearly · 2022-12-31 | Product | License | 100,000,000 | USD | 0001558370-25-001699 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Revenue | 6,602,000 | USD | 0001558370-23-002110 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Revenue Including Revenue From Related Party | 4,200,000 | USD | 0001558370-23-002110 |
| FY 2021Yearly · 2021-12-31 | Product | License | 517,400,000 | USD | 0001558370-23-002110 |
| FY 2021Yearly · 2021-12-31 | Product | License Revenue From Related Party | 0 | USD | 0001558370-23-002110 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Revenue | 59,000 | USD | 0001558370-23-002110 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Revenue From Related Party | 136,000 | USD | 0001558370-23-002110 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Revenue Including Revenue From Related Party | 200,000 | USD | 0001558370-23-002110 |
| FY 2020Yearly · 2020-12-31 | Product | License | 4,352,000 | USD | 0001558370-23-002110 |
| FY 2020Yearly · 2020-12-31 | Product | License Revenue From Related Party | 33,000,000 | USD | 0001558370-23-002110 |
| FY 2019Yearly · 2019-12-31 | Product | Collaborative Revenue From Related Party | 2,300,000 | USD | 0001558370-20-001883 |
| FY 2019Yearly · 2019-12-31 | Product | License Revenue From Related Party | 5,000,000 | USD | 0001558370-20-001883 |
| FY 2018Yearly · 2018-12-31 | Product | Collaborative Revenue From Related Party | 3,800,000 | USD | 0001558370-20-001883 |
| FY 2018Yearly · 2018-12-31 | Product | License Revenue From Related Party | 7,500,000 | USD | 0001558370-20-001883 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.